Why GE HealthCare Technologies ( GEHC ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why GE HealthCare Technologies ( GEHC ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.
GEHC vs. ESLOY: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies ( GEHC Quick QuoteGEHC - ) and EssilorLuxottica Unsponsored ADR ( ESLOY Quick QuoteESLOY - ) . But which of these two companies is the best option for those looking for undervalued stocks?
GE HealthCare ( GEHC ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Oct. 29, 2025 at 8:30 a.m. ETPresident and Chief Executive Officer - Peter J. ArduiniContinue reading ...
GE HealthCare Q3 Earnings and Revenues Beat Estimates, Net Margin Falls
GE HealthCare's Q3 results show steady revenue growth as strong imaging and diagnostics offset tariff and margin pressures.
GE HealthCare Technologies ( GEHC ) Surpasses Q3 Earnings and Revenue Estimates
GE HealthCare (GEHC) delivered earnings and revenue surprises of +1.90% and +1.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.
This Company Has Been Around Since 1892, and Its Stock is Up 80% This Year
GE Aerospace stock is soaring due to strong demand.
GE Healthcare Technologies: A Solid Investment or a Missed Opportunity?
Join us as we dissect GE Healthcare Technologies and reveal whether it's a smart investment choice or just another stock to avoid.
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
This Dollar Tree Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday - Dollar Tree ( NASDAQ:DLTR ) , Autoliv ( NYSE:ALV )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Chris Pierce downgraded the rating for TrueCar, Inc. ( NASDAQ:TRUE ) from Buy ...
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
Trump Administration Review Targets Medical Supply Chain - Becton Dickinson ( NYSE:BDX ) , Baxter Intl ( NYSE:BAX )
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports-including PPE, consumables, and medical devices-to assess reliance on foreign suppliers for critical health products.
Is it a Prudent Move to Retain BSX Stock in Your Portfolio for Now?
Boston Scientific's acquisitions and WATCHMAN growth fuel optimism, but currency swings and macro pressures weigh on its outlook.
Reasons to Add Labcorp Stock to Your Portfolio Right Now
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Should You Invest $1,000 in GE Stock Right Now?
Investors are excited about GE again... for good reason.
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon sees growth from surgical innovation and vision care products, but faces macro pressures and fierce competition.
GE HealthCare ( GEHC ) Upgraded to Strong Buy: What Does It Mean for the Stock?
GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
GE HealthCare debuts AI-powered Voluson Performance ultrasound systems, enhancing women's health imaging with faster, smarter diagnostics.
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.
Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?
Myriad Genetics expands oncology testing and launches new diagnostics, but inflation and rising competition weigh on its outlook.
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
WST rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
Here's Why You Should Add PAHC Stock to Your Portfolio Right Now
Phibro Animal Health posts strong Animal Health sales growth, aided by a Zoetis acquisition, while Mineral Nutrition and Performance Products rebound.
GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
GE HealthCare's FDA-cleared Revolution Vibe CT promises faster, AI-driven cardiac imaging with improved clarity, boosting efficiency and patient comfort.
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
GEHC Positioned for Growth With AI, Global Expansion and Margins
GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
New Strong Buy Stocks for August 15th
TEN, ECO, MOS, GEHC and SBFG have been added to the Zacks Rank #1 (Strong Buy) List on August 15, 2025.
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.
Tutor Perini and Crocs have been highlighted as Zacks Bull and Bear of the Day
Tutor Perini surges on a 386% earnings beat, record $21.1B backlog, and higher 2025 guidance, while Crocs struggles with tariff uncertainty.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down
AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands
DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
What Makes GE HealthCare ( GEHC ) a New Strong Buy Stock
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.
GEHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies ( GEHC Quick QuoteGEHC - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
GE HealthCare Technologies ( GEHC ) Q2 Earnings and Revenues Top Estimates
GE HealthCare (GEHC) delivered earnings and revenue surprises of +16.48% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.
Valneva ( VALN ) Soars 17.4%: Is Further Upside Left in the Stock?
Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
